Table 3 Oncological outcome
n (%) | Mean (SD) | |
|---|---|---|
PSA – nadir (ng/ml) | 101 | 0.6 (1.2) median: 0.1 (range: 0.01–6.50) |
Time to nadir (months) | 99 | 4.7 (5.7) |
Recurrencies | 31 (23.7%) | |
Biochemical recurrence (BCR) Suttgart criteria | 28 (21.4%) | |
low - risk - PCa | 10 (7.6%) | |
intermediate - risk – PCa | 12 (9.2%) | |
high - risk – PCa | 6 (4.6%) | |
Time to BCR (in months) (Stuttgart criteria) | 28 | 15.5 (11.6) |
Time to BCR (in months) (Phoenix criteria) | 17.4 (12.5) | |
low - risk - PCa | 10 | 14.1 (8.2) |
intermediate - risk - PCa | 12 | 19.8 (13.8) |
high - risk – Pca | 6 | 11.3 (5.4) |
Recurrence without BCR | 3 (2.3%) |